Patrick Reville

25PUBLICATIONS
132CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Oct 23, 2026
CD8 T-cell exhaustion linked with CAR T-cell failure can be mitigated by a non-alpha IL2 receptor agonist.

|Jul 09, 2025
An Isoform-Specific RUNX1C-BTG2 Axis Governs AML Quiescence and Chemoresistance.

Cuijuan Han, Zhiping Zhang, Edie I Crosse

|Jun 13, 2025
Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy-Ineligible Patients With Isocitrate Dehydrogenase-Mutated AML.

Courtney D DiNardo, Jennifer Marvin-Peek, Sanam Loghavi

|Apr 08, 2025
Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis.

Naval Daver, Jayastu Senapati, Hagop M Kantarjian

|Apr 03, 2025
Blood-based proteomic profiling identifies OSMR as a novel biomarker of AML outcomes.

Patrick K Reville, Bofei Wang, Jennifer Marvin-Peek

|Mar 31, 2025
Mutation dynamics from diagnosis to relapse in acute myeloid leukemia with chromosomal 7 deletions.

Eitan Kugler, Enes Dasdemir, Alex Bataller

Pageof 5

Frequent Collaborators

18 joint publications

Naval G Daver

17 joint publications

Courtney DiNardo

14 joint publications

Koji Sasaki

13 joint publications

Tapan M Kadia